![Peter Lamb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Peter Lamb worked at Ligand Pharmaceuticals, Inc. from 1992 to 2000 as Director-Transcription Research.
From 2000 to 2023, Dr. Lamb was at Exelixis, Inc., serving as Executive Vice President-Scientific Strategy from 2022 to 2023.
Dr. Lamb completed undergraduate studies at the University of Cambridge and earned a doctorate from the University of London.
Tidigare kända positioner av Peter Lamb
| Företag | Position | Slut |
|---|---|---|
| EXELIXIS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-12-15 |
| LIGAND PHARMACEUTICALS INCORPORATED | Företagsledare/Principal | 2000-09-01 |
Peter Lambs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
73
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
